Affinity Asset Advisors, LLC - Q4 2023 holdings

 Value Shares↓ Weighting
ExitROCKET PHARMACEUTICALS INC*w exp 09/02/202$0-75,000
-100.0%
-0.00%
ARAV ExitARAVIVE INC$0-346,511
-100.0%
-0.01%
NLSP ExitNLS PHARMACEUTICS LTD$0-200,455
-100.0%
-0.04%
ExitNEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202$0-137,000
-100.0%
-0.07%
ALDX ExitALDEYRA THERAPEUTICS INC$0-44,348
-100.0%
-0.08%
BCAB ExitBIOATLA INC$0-180,000
-100.0%
-0.09%
NUVB ExitNUVATION BIO INC$0-250,000
-100.0%
-0.09%
MESO ExitMESOBLAST LTDput$0-400,000
-100.0%
-0.14%
ExitCONTEXT THERAPEUTICS INC$0-328,817
-100.0%
-0.14%
ExitPROMIS NEUROSCIENCES INC$0-265,958
-100.0%
-0.15%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-202,349
-100.0%
-0.15%
ETNB Exit89BIO INCcall$0-37,300
-100.0%
-0.16%
IMTXW ExitIMMATICS N.V*w exp 07/01/202$0-187,204
-100.0%
-0.19%
AVRO ExitAVROBIO INC$0-500,000
-100.0%
-0.22%
ExitBIOHAVEN LTD$0-30,156
-100.0%
-0.22%
BBIO ExitBRIDGEBIO PHARMA INC$0-30,000
-100.0%
-0.22%
PODD ExitINSULET CORP$0-5,000
-100.0%
-0.22%
TVTX ExitTRAVERE THERAPEUTICS INC$0-100,000
-100.0%
-0.25%
MIRM ExitMIRUM PHARMACEUTICALS INC$0-30,000
-100.0%
-0.27%
SWTX ExitSPRINGWORKS THERAPEUTICS INC$0-41,581
-100.0%
-0.27%
IFRX ExitINFLARX NV$0-325,097
-100.0%
-0.27%
ADCT ExitADC THERAPEUTICS SA$0-1,100,000
-100.0%
-0.28%
ExitLIANBIOsponsored ads$0-672,357
-100.0%
-0.28%
MIST ExitMILESTONE PHARMACEUTICALS IN$0-335,068
-100.0%
-0.29%
ExitTHESEUS PHARMACEUTICALS INC$0-400,726
-100.0%
-0.30%
TALS ExitTALARIS THERAPEUTICS INC$0-400,000
-100.0%
-0.32%
MORF ExitMORPHIC HLDG INCput$0-50,000
-100.0%
-0.32%
ExitNEWAMSTERDAM PHARMA COMPANYordinary shares$0-125,000
-100.0%
-0.32%
EYPT ExitEYEPOINT PHARMACEUTICALS INCput$0-155,000
-100.0%
-0.35%
INSP ExitINSPIRE MED SYS INC$0-6,293
-100.0%
-0.35%
PCVX ExitVAXCYTE INC$0-25,000
-100.0%
-0.36%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-40,000
-100.0%
-0.43%
TERN ExitTERNS PHARMACEUTICALS INC$0-325,000
-100.0%
-0.46%
ExitROIVANT SCIENCES LTD$0-150,000
-100.0%
-0.49%
ACRS ExitACLARIS THERAPEUTICS INCput$0-260,000
-100.0%
-0.50%
NRIX ExitNURIX THERAPEUTICS INC$0-250,000
-100.0%
-0.55%
LNTH ExitLANTHEUS HLDGS INC$0-30,000
-100.0%
-0.59%
SGEN ExitSEAGEN INC$0-10,000
-100.0%
-0.60%
ExitNUVALENT INC$0-50,000
-100.0%
-0.65%
IMTX ExitIMMATICS N.V$0-200,000
-100.0%
-0.65%
MRTX ExitMIRATI THERAPEUTICS INC$0-60,426
-100.0%
-0.74%
KALV ExitKALVISTA PHARMACEUTICALS INC$0-278,292
-100.0%
-0.75%
ALKS ExitALKERMES PLC$0-100,000
-100.0%
-0.79%
ExitMOONLAKE IMMUNOTHERAPEUTICSclass a ord$0-50,000
-100.0%
-0.80%
DVAX ExitDYNAVAX TECHNOLOGIES CORP$0-200,000
-100.0%
-0.83%
ExitAEGLEA BIOTHERAPEUTICS INC$0-242,297
-100.0%
-0.84%
VKTX ExitVIKING THERAPEUTICS INC$0-300,000
-100.0%
-0.93%
MRSN ExitMERSANA THERAPEUTICS INC$0-2,850,000
-100.0%
-1.02%
VKTX ExitVIKING THERAPEUTICS INCput$0-332,600
-100.0%
-1.04%
PRTA ExitPROTHENA CORP PLC$0-79,214
-100.0%
-1.08%
ExitTANGO THERAPEUTICS INC$0-350,000
-100.0%
-1.11%
AZN ExitASTRAZENECA PLCsponsored adr$0-60,000
-100.0%
-1.14%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-150,000
-100.0%
-1.16%
ASND ExitASCENDIS PHARMA A/Ssponsored adr$0-46,400
-100.0%
-1.22%
SVRA ExitSAVARA INC$0-1,150,000
-100.0%
-1.22%
AUTL ExitAUTOLUS THERAPEUTICS PLCspon ads$0-1,992,466
-100.0%
-1.31%
IMVT ExitIMMUNOVANT INCput$0-128,100
-100.0%
-1.38%
APLS ExitAPELLIS PHARMACEUTICALS INCput$0-130,000
-100.0%
-1.39%
ALKS ExitALKERMES PLCcall$0-200,000
-100.0%
-1.58%
INZY ExitINOZYME PHARMA INC$0-1,379,852
-100.0%
-1.63%
VRNA ExitVERONA PHARMA PLCsponsored ads$0-368,329
-100.0%
-1.69%
MORF ExitMORPHIC HLDG INC$0-270,000
-100.0%
-1.74%
CNTA ExitCENTESSA PHARMACEUTICALS PLCsponsored ads$0-1,018,091
-100.0%
-1.85%
KRYS ExitKRYSTAL BIOTECH INC$0-57,500
-100.0%
-1.88%
CYTK ExitCYTOKINETICS INC$0-230,366
-100.0%
-1.91%
ESTA ExitESTABLISHMENT LABS HLDGS INCcall$0-140,000
-100.0%
-1.93%
ARKG ExitARK ETF TRput$0-250,000
-100.0%
-1.96%
ExitASTRIA THERAPEUTICS INC$0-1,000,300
-100.0%
-2.10%
KURA ExitKURA ONCOLOGY INC$0-856,535
-100.0%
-2.20%
XENE ExitXENON PHARMACEUTICALS INC$0-300,438
-100.0%
-2.89%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDcall$0-1,100,000
-100.0%
-3.16%
IMVT ExitIMMUNOVANT INC$0-300,000
-100.0%
-3.24%
ESTA ExitESTABLISHMENT LABS HLDGS INC$0-239,108
-100.0%
-3.30%
MDGL ExitMADRIGAL PHARMACEUTICALS INC$0-85,000
-100.0%
-3.49%
CRNX ExitCRINETICS PHARMACEUTICALS IN$0-450,000
-100.0%
-3.76%
ExitARCELLX INC$0-400,000
-100.0%
-4.04%
CERE ExitCEREVEL THERAPEUTICS HLDNG I$0-685,061
-100.0%
-4.21%
ExitBRIDGEBIO PHARMA INCnote 2.500% 3/1$0-17,000,000
-100.0%
-4.62%
CBAY ExitCYMABAY THERAPEUTICS INC$0-1,129,376
-100.0%
-4.74%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDsponsored ads$0-2,000,000
-100.0%
-5.74%
ExitAPOGEE THERAPEUTICS INC$0-1,045,110
-100.0%
-6.26%
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MORPHIC HOLDING INC12Q3 20236.9%
KURA ONCOLOGY INC12Q3 20237.2%
CELLDEX THERAPEUTICS INC NEW12Q3 20231.9%
IMMATICS N.V12Q3 20230.4%
CHINOOK THERAPEUTICS INC11Q2 20238.4%
ESTABLISHMENT LABS HLDGS INC11Q3 20238.3%
VINCERX PHARMA INC11Q2 20234.5%
ASCENDIS PHARMA A/S11Q3 20234.9%
CYTOKINETICS INC11Q3 20232.6%
INARI MED INC10Q1 20236.4%

View Affinity Asset Advisors, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Affinity Asset Advisors, LLC Q4 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aeglea BioTherapeutics, Inc.July 03, 20237,477,0009.2%

View Affinity Asset Advisors, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-05-07
13F-HR2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR/A2023-08-21
13F-HR2023-08-14
SC 13G2023-07-03
13F-HR2023-05-15

View Affinity Asset Advisors, LLC's complete filings history.

Compare quarters

Export Affinity Asset Advisors, LLC's holdings